Compare GMED & JEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GMED | JEF |
|---|---|---|
| Founded | 2003 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.3B | 10.5B |
| IPO Year | 2012 | N/A |
| Metric | GMED | JEF |
|---|---|---|
| Price | $86.68 | $61.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 5 |
| Target Price | ★ $93.09 | $76.00 |
| AVG Volume (30 Days) | 1.6M | ★ 1.7M |
| Earning Date | 11-06-2025 | 01-07-2026 |
| Dividend Yield | N/A | ★ 2.58% |
| EPS Growth | ★ 358.86 | 25.06 |
| EPS | ★ 3.08 | 2.92 |
| Revenue | $2,769,804,000.00 | ★ $7,231,501,000.00 |
| Revenue This Year | $16.66 | $5.85 |
| Revenue Next Year | $8.27 | $9.97 |
| P/E Ratio | $28.15 | ★ $21.42 |
| Revenue Growth | 11.75 | ★ 15.68 |
| 52 Week Low | $51.79 | $39.28 |
| 52 Week High | $94.93 | $82.68 |
| Indicator | GMED | JEF |
|---|---|---|
| Relative Strength Index (RSI) | 58.56 | 64.62 |
| Support Level | $87.72 | $55.98 |
| Resistance Level | $91.12 | $63.92 |
| Average True Range (ATR) | 2.16 | 1.84 |
| MACD | -1.11 | 0.67 |
| Stochastic Oscillator | 15.43 | 78.41 |
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Jefferies is a full-service investment banking and capital markets firm that was founded in 1962. After nearly 30 years of focusing on institutional trading services, it entered the investment banking industry in the early 1990s, which ultimately grew into the core business. In 2013, Jefferies merged with Leucadia, a manufacturing-focused holding company. Since merging, Jefferies became the bedrock of the business as the bulk of the legacy portfolio was sold off and the parent company was renamed to match the subsidiary. Within the investment banking landscape, Jefferies predominately serves the North American middle market and has captured considerable market share over the past decade.